Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HiCardi+ H100

K-Number: K232670 · 2024-09-20

Decision Date2024-09-20
Product CodeDSH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

HiCardi+ H100 is a medical device manufactured by MEZOO Co., Ltd.. It received FDA 510(k) clearance on 2024-09-20 under approval number K232670. The device is classified under product code DSH. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HiCardi+ H100?

HiCardi+ H100 is a medical device that received FDA 510(k) clearance on 2024-09-20. It is manufactured by MEZOO Co., Ltd.. The 510(k) number is K232670.

When was HiCardi+ H100 approved by the FDA?

HiCardi+ H100 received FDA 510(k) clearance on 2024-09-20, under approval number K232670.

What company makes HiCardi+ H100?

HiCardi+ H100 is manufactured by MEZOO Co., Ltd..

What is the FDA product code for HiCardi+ H100?

The FDA product code for HiCardi+ H100 is DSH.

Related Devices (Code: DSH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.